HomeMARI • VIE
add
Marinomed Biotech AG
Previous close
€20.10
Year range
€7.00 - €21.00
Market cap
36.98M EUR
Avg Volume
663.00
P/E ratio
2.00
Dividend yield
-
Primary exchange
VIE
Market news
The Globe and Mail
22 hours ago
TSX falls the most in six months as gold slides and inflation heats up
1.73%
Financials
Income Statement
Revenue
Net income
| (EUR) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 918.87K | -46.38% |
Operating expense | 19.96M | 909.27% |
Net income | -1.38M | 18.01% |
Net profit margin | -150.15 | -52.90% |
Earnings per share | — | — |
EBITDA | -20.25M | -1,522.72% |
Effective tax rate | 7.83% | — |
Balance Sheet
Total assets
Total liabilities
| (EUR) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.49M | 63.18% |
Total assets | 7.64M | -32.51% |
Total liabilities | 13.08M | -58.95% |
Total equity | -5.44M | — |
Shares outstanding | 1.78M | — |
Price to book | -6.57 | — |
Return on assets | — | — |
Return on capital | -1,182.15% | — |
Cash Flow
Net change in cash
| (EUR) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -1.38M | 18.01% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
2006
Website
Employees
33
